Fusion Antibodies is a Collaborative Research Organisation (CRO) with its headquarters in Northern Ireland. We are world leaders in antibody development services specializing in the discovery, engineering and supply of pre-clinical biologics through to clinical Cell Line Development.
| CEO: |
Adrian Kinkaid |
| Chairman: |
Simon Gordon Douglas |
| Non-Executive Director: |
Matthew Baker, Colin Walsh |
| Chief Scientific Officer: |
Richard John Buick |
| Address: |
Springbank Industrial Estate, 1 Springbank Rd, Dunmurry, Belfast, United Kingdom |
| Phone: |
|
| Fax: |
|
| Website: |
https://www.fusionantibodies.com/ |
| Email: |
|